News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 184
- Sources here
- 18
- Companies here
- 5
Active search
184 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer
Rainer Blair to retire WASHINGTON, Aug. 3, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, …
Danaher's Rainer Blair to Retire; Julie Sawyer Montgomery Starts Oct. 1
Danaher (NYSE: DHR) has announced that Julie Sawyer Montgomery will become its new President and Chief Executive Officer, effective October 1, 2026. She will succeed Rainer Blair, who is retiring and will serve as a senior advisor during the transition period. Montgomery has been …
Danaher stock rises after naming new CEO, backing guidance
Danaher Corporation's shares rose 2% after hours following the announcement of Julie Sawyer Montgomery as the new President and CEO, effective October 1, 2026. The company also reaffirmed its previously communicated financial guidance for the third quarter and full year 2026. Montgomery, who has …
Danaher Corp. stock rises Monday, still underperforms market
Shares of Danaher Corp. (DHR) increased by 1.29% on Monday, closing at $197.50, despite the broader market also seeing gains with the S&P 500 up 1.48% and the Dow Jones Industrial Average up 1.32%. This rise for Danaher snapped a three-day losing streak, though …
Danaher: CEO Change Comes Amid Challenging Times for Company
Danaher announced a CEO transition from Rainer Blair to Julie Sawyer Montgomery, a diagnostics leader, on August 3. Shares rose about 2% in after-hours trading following this news. This change comes as the company faces challenging times, including bioprocessing delays mentioned in recent analyst …
Danaher Corp. (1DHR) Q2 2026 Earnings Report - Results, Call & Slides
Danaher Corporation (1DHR) reported strong Q2 2026 earnings, beating analyst expectations for both EPS and revenue. The company saw accelerating core growth, robust cash generation, and raised its full-year EPS guidance despite headwinds from bioprocessing shipment timing and respiratory-related issues. Strategic M&A and share …
Danaher Stock vs XHB ETF: Complete Performance Comparison
This article compares Danaher (DHR) stock, a life sciences and diagnostics company, with the XHB ETF, which tracks homebuilding companies, across returns, risk, and dividends. It highlights Danaher's strong fundamentals and dividend record against XHB's exposure to the volatile housing market, guiding investors to …
Danaher Number of Employees 2026 | Employee Count & Headcount Data
Danaher Corp. (DHR) had approximately 60,225 employees worldwide as of March 2026, representing a 0.8% decline from 2023. The company is actively hiring, with 6,341 active job postings in 2026, a 14.2% increase from 2025. Danaher's workforce is concentrated in the United States, India, …
Danaher Corp. stock underperforms Wednesday when compared to competitors
Danaher Corp. (DHR) stock fell by 1.29% to $196.49 on Wednesday, ending a two-day winning streak. This underperformance occurred during a generally poor trading session, with the S&P 500 Index (SPX) dropping 1.52% and the Dow Jones Industrial Average (DJIA) declining 2.19%.
Danaher Corp Lobbyists, 2023
This OpenSecrets.org page details the lobbying activities of Danaher Corp in 2023. It lists 33 lobbyists, with 20 of them having prior federal government experience (revolving door). The page breaks down lobbyists by hiring firm, including Brownstein, Hyatt et al, Todd Strategy Group, Fulcrum …
Danaher Corp Lobbyists, 2002
This OpenSecrets.org page details the lobbyists who represented Danaher Corp in 2002. It lists 13 lobbyists, with 8 having revolving door experience (former federal government employees), including one former member of Congress. The data also specifies the firms employing these lobbyists, primarily Dickstein Shapiro …
Danaher Corp (DHR) Institutional Confidence
Danaher Corp (DHR) has an institutional shareholding score of 7.00, placing it 78th in the Healthcare Equipment & Supplies industry. This score reflects an institutional shareholding proportion of 83.99%, which decreased by 0.84% quarter-over-quarter. The largest institutional shareholder is Al Gore, holding 7.97M shares, …
Orange Investment Advisors, Inc.'s Danaher Corp(DHR) Holding History
This article details Orange Investment Advisors, Inc.'s historical holdings in Danaher Corp (DHR). As of June 30, 2026, the firm held 1,434 shares valued at $273,150, representing 0.03% of their portfolio. The firm has made 21 purchases and 14 sales of DHR since 2017Q1, …
DHR|Danaher Corp|Price:196.510|Chg%:+5.010
This article provides a comprehensive stock analysis of Danaher Corp (DHR) by TradingKey, highlighting its healthy fundamentals, high growth potential, and relatively fair valuation. It notes high institutional ownership, multiple "Buy" ratings from analysts with a target price of 220.02, and a stable medium-term …
Danaher Corp (DHR) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Danaher Corp (DHR), highlighting its current valuation score, market capitalization, and P/E ratio. DHR's current P/E ratio of 37.84 is below its recent high and above its recent low. The article notes that relevant data for P/B, …
(DHR) Movement as an Input in Quant Signal Sets
This article analyzes Danaher Corporation (NYSE: DHR) using AI models to provide quantitative signal sets. It identifies a mid-channel oscillation pattern with a significant risk-reward setup targeting a 12.1% gain. The report offers distinct trading strategies (Position, Momentum Breakout, Risk Hedging) tailored for different …
Is Danaher (DHR) Using Buybacks to Reinforce Its Earnings Story Amid Slower Revenue Guidance?
Danaher Corporation reported improved Q2 2026 sales and net income, alongside modest Q3 revenue guidance of 2-3% due to a respiratory testing headwind. The company has also completed over US$4.79 billion in share repurchases, reducing its share count. This strategy aims to support its …
Danaher Corporation Revenue Breakdown – BX:DAP
This article provides a brief overview of Danaher Corporation's revenue breakdown. In the last fiscal year, the company generated CHF 19.48 billion in revenue, with the Diagnostics segment being the top performer contributing CHF 7.88 billion. The United States was the largest geographical contributor, …
Danaher (DHR) Could Be 16% Undervalued On Earnings And 2026 Revenue Guidance
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Danaher (DHR) has attracted investor attention after issuing third quarter 2026 revenue guidance of 2% to 3% growth, alongside detailing recent share repurchases …
Sharemaestro market context Price above Trend Line 52 weeks -11.4%Danaher (DHR) Stock Tries To Steady After A Sharp Post Earnings Selloff
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Danaher (NYSE:DHR) shares saw a sharp post earnings selloff, with heavy trading activity highlighting strong investor reaction. Following the drop, the stock closed near its daily highs, …
Sharemaestro market context Price above Trend Line 52 weeks -11.4%Danaher Corp (DHR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Danaher Corp (DHR), detailing its regional revenue contributions. Although segment data is not yet disclosed for future fiscal years, the current data shows that the United States accounts for 40.63% of revenue, China for 10.71%, and other …
Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
Shareholders in biotechnology, life sciences, and diagnostics solutions company Danaher (NYSE: DHR) have had an interesting week. Their stock crashed early in the week on the release of its second-quarter earnings, only to recover somewhat through the week and start Friday morning having declined …
Sharemaestro market context Price above Trend Line 52 weeks -11.4%Cepheid Appoints Piotr Zima Chief Information Officer
Cepheid, a Danaher Corporation subsidiary focused on molecular diagnostics, has appointed Piotr Zima as its new Chief Information Officer (CIO). Zima previously served as Vice President, Chief Information Officer at Integrated DNA Technologies and held data and analytics roles within Danaher. He expressed his …
Danaher Corp Stock (DHR) Moved Up by 6.78% on Jul 23: What Signal Does It Send?
Danaher Corp (DHR) stock rose 6.78% due to strong quarterly results, exceeding analyst expectations, and indicating a recovery in bioprocessing demand. Management raised full-year earnings and revenue guidance, reflecting confidence in sustainable growth across its biotechnology and life sciences segments. Broader market dynamics and …
Guggenheim cuts Danaher stock price target to $200 on bioprocessing concerns
Guggenheim has reduced its price target for Danaher Corp. (DHR) to $200 from $235, while maintaining a Buy rating, due to ongoing concerns about the bioprocessing market. Despite Danaher exceeding Q2 2026 earnings and revenue estimates, investor sentiment remains subdued, and several analysts have …